FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
+6.06%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$41.9B
AUM Growth
-$427M
(-1%)
Cap. Flow
+$69.7M
Cap. Flow
% of AUM
0.17%
Top 10 Holdings %
Top 10 Hldgs %
26.21%
Holding
592
New
84
Increased
188
Reduced
187
Closed
80
Top Buys
| 1 |
Tesla
TSLA
|
$488M |
| 2 |
Sea Limited
SE
|
$326M |
| 3 |
Advanced Micro Devices
AMD
|
$290M |
| 4 |
InMode
INMD
|
$191M |
| 5 |
Apple
AAPL
|
$182M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$293M |
| 2 |
Alphabet (Google) Class C
GOOG
|
$267M |
| 3 |
Pinterest
PINS
|
$187M |
| 4 |
NXP Semiconductors
NXPI
|
$168M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
$147M |
Sector Composition
| 1 | Technology | 34.68% |
| 2 | Healthcare | 20.73% |
| 3 | Consumer Discretionary | 14.7% |
| 4 | Financials | 8.79% |
| 5 | Industrials | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Bumble
BMBL
$697M
| $3.97M | 0.01% |
79,493
+1,374
| +2% | +$68.7K |
|
302
Johnson & Johnson
JNJ
$430B
| $3.95M | 0.01% |
24,471
-360
| -1% | -$58.1K |
|
|
AKYA
303
DELISTED
Akoya BioSciences
AKYA
| $3.95M | 0.01% |
282,778
+4,452
| +2% | +$62.2K |
|
304
West Pharmaceutical
WST
$18B
| $3.89M | 0.01% |
9,161
| – | – |
|
305
Hexcel
HXL
$5.16B
| $3.83M | 0.01% |
64,503
+1,129
| +2% | +$67.1K |
|
306
Grifois
GRFS
$6.89B
| $3.77M | 0.01% |
257,938
| – | – |
|
307
PMV Pharmaceuticals
PMVP
$77.4M
| $3.73M | 0.01% |
+125,211
| New | +$3.73M |
|
308
Wayfair
W
$11.6B
| $3.69M | 0.01% |
14,447
-29,075
| -67% | -$7.43M |
|
309
STAAR Surgical
STAA
$1.38B
| $3.63M | 0.01% |
28,201
-1,819
| -6% | -$234K |
|
310
PTC
PTC
$25.6B
| $3.55M | 0.01% |
29,602
-53,221
| -64% | -$6.38M |
|
311
McKesson
MCK
$85.5B
| $3.53M | 0.01% |
17,699
-16,679
| -49% | -$3.33M |
|
|
DCPH
312
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $3.51M | 0.01% |
+103,148
| New | +$3.51M |
|
313
Essex Property Trust
ESS
$17.3B
| $3.43M | 0.01% |
+10,738
| New | +$3.43M |
|
|
KRTX
314
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $3.43M | 0.01% |
28,025
+409
| +1% | +$50K |
|
315
AvalonBay Communities
AVB
$27.8B
| $3.4M | 0.01% |
+15,354
| New | +$3.4M |
|
316
Seacoast Banking Corp of Florida
SBCF
$2.75B
| $3.38M | 0.01% |
+100,000
| New | +$3.38M |
|
317
ClearPoint Neuro
CLPT
$314M
| $3.38M | 0.01% |
+190,391
| New | +$3.38M |
|
318
AbbVie
ABBV
$375B
| $3.33M | 0.01% |
30,912
-89,167
| -74% | -$9.62M |
|
319
Comcast
CMCSA
$125B
| $3.27M | 0.01% |
58,446
+929
| +2% | +$52K |
|
320
Dynatrace
DT
$15.1B
| $3.2M | 0.01% |
45,034
-53,403
| -54% | -$3.79M |
|
321
BioMarin Pharmaceuticals
BMRN
$11.1B
| $3.16M | 0.01% |
40,852
+2,701
| +7% | +$209K |
|
322
Verizon
VZ
$187B
| $3.14M | 0.01% |
58,089
| – | – |
|
323
Air Products & Chemicals
APD
$64.5B
| $3.04M | 0.01% |
11,881
-154,913
| -93% | -$39.7M |
|
324
Relay Therapeutics
RLAY
$710M
| $2.96M | 0.01% |
+93,938
| New | +$2.96M |
|
|
ALTR
325
DELISTED
Altair Engineering Inc. Class A Common Stock
ALTR
| $2.95M | 0.01% |
42,804
-45,077
| -51% | -$3.11M |
|